Reid Hoffman to Leave Microsoft Board for AI Startup Manus

*LinkedIn co-founder Reid Hoffman will step down from Microsoft’s board later this year to focus on his AI drug discovery company.*

Reid Hoffman is leaving Microsoft’s board after roughly ten years. The move lets him direct more time toward Manus, an artificial intelligence startup working on drug discovery.

Bloomberg reports the departure will occur later this year. TechCrunch states the decision follows a decade on the board during which Hoffman contributed to Microsoft’s direction.

The two accounts align on the reason: Hoffman wants to shift his attention to Manus. No other details on timing or successor have been released.

Why it matters

Microsoft loses a board member with deep ties to both enterprise software and the venture capital world. The change is unlikely to alter day-to-day operations yet signals that Hoffman sees greater leverage in applying large-scale models to pharmaceutical research than in continued governance at a mature public company.

---

Sources:

• TechCrunch
• Bloomberg Technology

{
  "excerpt": "Reid Hoffman will leave Microsoft’s board later this year to focus on his AI drug discovery startup Manus.",
  "suggestedSection": "business",
  "suggestedTags": ["reid-hoffman", "microsoft-board"],
  "imagePrompt": "An empty conference table with scattered documents beside a row of laboratory glassware under low overhead light. Abstract forms suggest transition between corporate and research settings, muted color palette, cinematic lighting, 16:9."
}